TrialRheumatology international2023

Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial.

Sreeja S Bhat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.